Elena Dneprovskaia

Person

San Diego, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
AKT1 modulators
- Patent number 12,209,087
- Issue date Jan 28, 2025
- ALTEROME THERAPEUTICS, INC.
- Michael David Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
AKT1 modulators
- Patent number 11,999,730
- Issue date Jun 4, 2024
- ALTEROME THERAPEUTICS, INC.
- Michael David Bartberger
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Benzotriazine inhibitors of kinases
- Patent number 8,481,536
- Issue date Jul 9, 2013
- TargeGen, Inc.
- Xianchang Gong
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and methods of use
- Patent number 8,372,971
- Issue date Feb 12, 2013
- TargeGen, Inc.
- Wolfgang Wrasidlo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Heterocyclic compounds and methods of use
- Patent number 8,084,618
- Issue date Dec 27, 2011
- TargeGen, Inc.
- Wolfgang Wrasidlo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
2-amino—5-substituted pyrimidine inhibitors
- Patent number 8,030,487
- Issue date Oct 4, 2011
- TargeGen, Inc.
- Glenn Noronha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Kinase inhibitors and methods of use thereof
- Patent number 7,691,858
- Issue date Apr 6, 2010
- TargeGen, Inc.
- John Doukas
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Heterocyclic compounds and methods of use
- Patent number 7,652,051
- Issue date Jan 26, 2010
- TargeGen, Inc.
- Wolfgang Wrasidlo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Benzotriazine inhibitors of kinases
- Patent number 7,456,176
- Issue date Nov 25, 2008
- TargeGen, Inc.
- Glenn Noronha
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Vasculostatic agents and methods of use thereof
- Patent number 7,208,493
- Issue date Apr 24, 2007
- TargeGen, Inc.
- Wolfgang Wrasidlo
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
FXR NR1H4 nuclear receptor binding compounds
- Patent number 7,098,336
- Issue date Aug 29, 2006
- Phenex Pharmaceuticals AG
- Ulrike Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NR1H4 nuclear receptor binding compounds
- Patent number 7,034,046
- Issue date Apr 25, 2006
- Phenex Pharmaceuticals AG
- Ulrike Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
NR1H4 nuclear receptor binding compounds
- Patent number 6,974,830
- Issue date Dec 13, 2005
- Phenix Pharmaceuticals AG
- Ulrike Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
AKT1 MODULATORS
- Publication number 20240239797
- Publication date Jul 18, 2024
- Alterome Therapeutics, Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AKT1 MODULATORS
- Publication number 20240174667
- Publication date May 30, 2024
- Alterome Therapeutics, Inc.
- Michael David BARTBERGER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOUNDS AND METHODS FOR TREATING CANCER
- Publication number 20220204482
- Publication date Jun 30, 2022
- ANTIDOTE IP HOLDINGS, LLC
- Elena V. Dneprovskaia
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOUNDS AND METHODS FOR TREATING CANCER
- Publication number 20200299282
- Publication date Sep 24, 2020
- ANTIDOTE IP HOLDINGS, LLC
- Michael S. Holzwarth
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
- Publication number 20130243754
- Publication date Sep 19, 2013
- TargeGen, Inc.
- Wolfgang Wrasidlo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
- Publication number 20120220584
- Publication date Aug 30, 2012
- TargeGen, Inc.
- Wolfgang Wrasidlo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
BENZOTRIAZINE INHIBITORS OF KINASES
- Publication number 20110294796
- Publication date Dec 1, 2011
- TargeGen, Inc.
- Xianchang Gong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Vasculostatic Agents and Methods of Use Thereof
- Publication number 20100330030
- Publication date Dec 30, 2010
- TargeGen, Inc.
- Wolfgang Wrasidlo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS AND METHODS OF USE
- Publication number 20100330069
- Publication date Dec 30, 2010
- TargeGen, Inc.
- Wolfgang Wrasidlo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VASCULOSTATIC AGENTS AND METHODS OF USE THEREOF
- Publication number 20100278811
- Publication date Nov 4, 2010
- TargeGen Inc.
- Wolfgang Wrasidlo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzotriazine Inhibitors of Kinases
- Publication number 20090275569
- Publication date Nov 5, 2009
- Xianchang Gong
- C07 - ORGANIC CHEMISTRY
Information Patent Application
2-AMINO--5-SUBSTITUTED PYRIMIDINE INHIBITORS
- Publication number 20080027070
- Publication date Jan 31, 2008
- TargeGen, Inc.
- Glenn Noronha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Kinase inhibitors and methods of use thereof
- Publication number 20070259876
- Publication date Nov 8, 2007
- TargeGen, Inc.
- John Doukas
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Vasculostatic agents and methods of use thereof
- Publication number 20070208019
- Publication date Sep 6, 2007
- TARGEGEN, INC.
- Wolfgang Wrasidlo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Thiazole inhibitors targeting resistant kinase mutations
- Publication number 20070161645
- Publication date Jul 12, 2007
- TargeGen, Inc.
- Glenn Noronha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Six membered heteroaromatic inhibitors targeting resistant kinase m...
- Publication number 20070149508
- Publication date Jun 28, 2007
- TargeGen, Inc.
- Glenn Noronha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Nr1h4 nuclear receptor binding compounds
- Publication number 20070010562
- Publication date Jan 11, 2007
- Ulrike Bauer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Heterocyclic compounds and methods of use
- Publication number 20060079526
- Publication date Apr 13, 2006
- TargeGen, Inc.
- Wolfgang Wrasidlo
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Vasculostatic agents and methods of use thereof
- Publication number 20050282814
- Publication date Dec 22, 2005
- TargeGen, Inc.
- Wolfgang Wrasidlo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Benzotriazine inhibitors of kinases
- Publication number 20050245524
- Publication date Nov 3, 2005
- TargeGen, Inc.
- Glenn Noronha
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Vasculostatic agents and methods of use thereof
- Publication number 20040167198
- Publication date Aug 26, 2004
- TargeGen, Inc.
- Wolfgang Wrasidlo
- C07 - ORGANIC CHEMISTRY
Information Patent Application
NR1H4 nuclear receptor binding compounds
- Publication number 20030187042
- Publication date Oct 2, 2003
- Ulrike Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
NR1H4 nuclear receptor binding compounds
- Publication number 20030149087
- Publication date Aug 7, 2003
- Ulrike Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
FXR NR1H4 nuclear receptor binding compounds
- Publication number 20030130296
- Publication date Jul 10, 2003
- Ulrike Bauer
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Elena Dneprovskaia

Person

Patents Grantslast 30 patents

AKT1 modulators

AKT1 modulators

Benzotriazine inhibitors of kinases

Heterocyclic compounds and methods of use

Heterocyclic compounds and methods of use

2-amino—5-substituted pyrimidine inhibitors

Kinase inhibitors and methods of use thereof

Heterocyclic compounds and methods of use

Benzotriazine inhibitors of kinases

Vasculostatic agents and methods of use thereof

FXR NR1H4 nuclear receptor binding compounds

NR1H4 nuclear receptor binding compounds

NR1H4 nuclear receptor binding compounds

Patents Applicationslast 30 patents

AKT1 MODULATORS

AKT1 MODULATORS

COMPOUNDS AND METHODS FOR TREATING CANCER

COMPOUNDS AND METHODS FOR TREATING CANCER

HETEROCYCLIC COMPOUNDS AND METHODS OF USE

HETEROCYCLIC COMPOUNDS AND METHODS OF USE

BENZOTRIAZINE INHIBITORS OF KINASES

Vasculostatic Agents and Methods of Use Thereof

HETEROCYCLIC COMPOUNDS AND METHODS OF USE

VASCULOSTATIC AGENTS AND METHODS OF USE THEREOF

Benzotriazine Inhibitors of Kinases

2-AMINO--5-SUBSTITUTED PYRIMIDINE INHIBITORS

Kinase inhibitors and methods of use thereof

Vasculostatic agents and methods of use thereof

Thiazole inhibitors targeting resistant kinase mutations

Six membered heteroaromatic inhibitors targeting resistant kinase m...

Nr1h4 nuclear receptor binding compounds

Heterocyclic compounds and methods of use

Vasculostatic agents and methods of use thereof

Benzotriazine inhibitors of kinases

Vasculostatic agents and methods of use thereof

NR1H4 nuclear receptor binding compounds

NR1H4 nuclear receptor binding compounds

FXR NR1H4 nuclear receptor binding compounds